About Atomic AI
Atomic AI is a biotechnology company fusing artificial intelligence and structural biology to unlock RNA drug discovery. Its proprietary R&D platform, anchored by ATOM-1 — a foundation model for RNA structure prediction — integrates deep learning models with in-house wet-lab assays to design RNA-targeted small molecules and RNA-based medicines. The company targets pharmaceutical and biotech customers seeking to treat previously undruggable diseases by leveraging RNA structure.
Company details
Funding
Total raised
$115M
Last stage
Series A
Investors
Founders
Raphael Townshend
Expert in machine learning and structural biology who identified the need to target RNA with small molecules using AI.
LinkedInStephan Eismann
Founding scientist and machine learning lead at Atomic AI.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.